Vimarsana
Biggest News Aggregation in the World

Page 4 - Dan Gooding News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dan Gooding. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dan Gooding Today - Breaking & Trending Today

Nuformix loss narrows; near-term goal to focus on NXP002 asset - Vimarsana News

Nuformix loss narrows; near-term goal to focus on NXP002 asset

Nuformix PLC on Monday reported a narrowed annual loss as it made progress on optimising costs and furthering its lead asset, NXP002. Nuformix is a London-based pharmaceutical development company... | May 22, 2023

Nuformix says NXP002 shows anti-inflammatory effect - Vimarsana News

Nuformix says NXP002 shows anti-inflammatory effect

The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: ---------- Sareum Holdings PLC - Cambridge-based biotechnology... | May 18, 2023

Nuformix to raise £70,000 for support the overall progression of the NXP002 programme - Vimarsana News

Nuformix to raise £70,000 for support the overall progression of the NXP002 programme

Nuformix to raise £70,000 for support the overall progression of the NXP002 programme

Nuformix raises GBP70,000 to fund NXP002 programme - Vimarsana News

Nuformix raises GBP70,000 to fund NXP002 programme

Nuformix PLC on Monday said it has raised GBP70,000 through a subscription for 35.0 million new shares at a price of 0.20 pence each. Nuformix is a London-based pharmaceutical development company... | April 17, 2023

Nuformix "tranilast at the heart of NXP002" in treating fibrosis (LON:NXF) - Vimarsana News

Nuformix "tranilast at the heart of NXP002" in treating fibrosis (LON:NXF)

Nuformix "tranilast at the heart of NXP002" in treating fibrosis (LON:NXF)